Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novatech is a global leader in the field of interventional pulmonology, specializing in the development and manufacture of tracheobronchial stents and related medical devices. Founded by the pioneer of silicone stenting, Dr. Jean-François Dumon, the company is best known for its DUMON silicone stents, which remain the gold standard for treating complex airway obstructions. In addition to its extensive stent portfolio, Novatech produces STERITALC, a high-purity talc used for pleurodesis in patients with malignant pleural effusions or recurrent pneumothorax. The company's products are essential tools for pulmonologists and thoracic surgeons worldwide, supported by a robust distribution network across more than 60 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novatech.